Skip to main content
Clinical Trials/ACTRN12618001028291
ACTRN12618001028291
Not yet recruiting
未知

Pilot study to assess safety, accuracy and ease of use of the Tournicare BP monitor compared with a clinically validated BP monitor based on multiple measurements on up to 30 generally healthy adult participants.

Tournicare Pty Ltd0 sites30 target enrollmentJune 19, 2018
ConditionsBlood Pressure

Overview

Phase
未知
Intervention
Not specified
Conditions
Blood Pressure
Sponsor
Tournicare Pty Ltd
Enrollment
30
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tournicare Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200
Recruiting
Not Applicable
Pilot study to evaluate the efficacy and safety of MegaNuovo in Pressure sore patients : single center, comparative, investigator-initiated pilot studyDiseases of the skin and subcutaneous tissue
KCT0006745Yonsei University, Wonju Severance Christian Hospital30
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucoma
ISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patients
ISRCTN86839890Transcend Medical, Inc.™ (USA)20
Active, not recruiting
Not Applicable
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]Non Familial Chylomicronemia Syndrome (Non-FCS)
EUCTR2012-000872-40-CZovartis Pharma Services AG60